Abstract
Interactions between genetic and environmental factors are implicated in the onset of rheumatoid arthritis (RA). There is an increasing appreciation for the association between intestinal microbiome and RA susceptibility. Alterations in intestinal microbiome in untreated patients and patients with established RA on treatment when compared to healthy individuals suggest that intestinal microbiota can be used as a predictor for risk as well as for treatment response. Intestinal microbial composition is strongly influenced by many factors including diet and infections. There is limited information on the use of diet and probiotics to manipulate microbiome and manage RA. Current treatments for RA produce variable response, and responders rarely achieve sustained remission requiring ongoing therapies. Biomarkers that can predict prognosis and therapeutic responses are lacking. Deciphering the use of endogenous commensals with probiotic-like properties and designing probiotics with targeted proteins would help manage RA without the side effects of immunosuppressive treatments. This chapter presents the key concepts of microbial interactions with the host immune system in pathogenicity of rheumatoid arthritis. Also discussed are treatment opportunities using novel treatment strategies such as the use of endogenous commensals and deliberated possible next-generation microbial therapeutics.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- AA:
-
Amino acids
- ACPs:
-
Anti-citrullinated antibodies
- AD:
-
African descent
- APCs:
-
Antigen-presenting cells
- BAFF:
-
B cell-activating factor
- BM:
-
Bone marrow
- CIA:
-
Collagen-induced arthritis
- CRP:
-
C-reactive protein
- DCs:
-
Dendritic cells
- DMARDs:
-
Disease-modifying antirheumatic drugs
- DNA:
-
Deoxyribonucleic acid
- DSS:
-
Dextran sulfate sodium
- EBV:
-
Epstein–Barr virus
- EBVNA1:
-
EBV nuclear antigen 1
- ED:
-
European descent
- FMT:
-
Fecal microbiota transplantation
- GF:
-
Germ-free
- GMPs:
-
Genetically modified probiotics
- GPCRs:
-
G-protein-coupled receptors
- GWAS:
-
Genome-wide association studies
- HLA :
-
Histocompatibility antigens
- IBD :
-
Inflammatory bowel disease
- IFN:
-
Interferon
- IgA:
-
Immunoglobulin A
- IL:
-
Interleukin
- ILC3s :
-
Group 3 innate lymphoid cells
- IRAK :
-
IL-1R-associated kinase
- MCP:
-
Monocyte chemoattractant protein
- MHC:
-
Major histocompatibility complex
- MS:
-
Multiple sclerosis
- MTX:
-
Methotrexate
- MUFAs:
-
Monosaturated fatty acids
- NGBTs:
-
Next-generation bacterial therapeutics
- NLRs:
-
Nod-like receptors
- NORA:
-
New-onset RA
- PAD:
-
Peptidyl arginine deiminase
- PAMPs:
-
Pathogen-associated molecular patterns
- PRRs:
-
Pathogen recognition receptors
- PUFAs:
-
Polyunsaturated fatty acids
- RA:
-
Rheumatoid arthritis
- RNA:
-
Ribonucleic acid
- SCFAs:
-
Short-chain fatty acids
- SFB:
-
Segmented filamentous bacteria
- SLE:
-
Systemic lupus erythematosus
- T1D:
-
Type 1 diabetes
- Th17:
-
T helper 17
- TIR:
-
Toll/interleukin-1 receptor
- TLRs:
-
Toll-like receptors
- TNF:
-
Tumor necrosis factor
- TRAF6:
-
TNF- associated factor 6
References
Abdollahi-Roodsaz S, Joosten LA, Koenders MI, Devesa I, Roelofs MF, Radstake TR, Heuvelmans-Jacobs M, Akira S, Nicklin MJ, Ribeiro-Dias F, Van Den Berg WB (2008) Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest 118:205–216
Alipour B, Homayouni-Rad A, Vaghef-Mehrabany E, Sharif SK, Vaghef-Mehrabany L, Asghari-Jafarabadi M, Nakhjavani MR, Mohtadi-Nia J (2014) Effects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: a randomized double-blind clinical trial. Int J Rheum Dis 17:519–527
Amdekar S, Roy P, Singh V, Kumar A, Singh R, Sharma P (2012) Anti-inflammatory activity of lactobacillus on carrageenan-induced paw edema in male Wistar rats. Int J Inflam 2012:752015
Amedei A, Bergman MP, Appelmelk BJ, Azzurri A, Benagiano M, Tamburini C, Van Der Zee R, Telford JL, Vandenbroucke-Grauls CMJE, D'elios MM, Del Prete G (2003) Molecular mimicry between helicobacter pylori antigens and H+,K+-adenosine triphosphatase in human gastric autoimmunity. J Exp Med 198:1147–1156
Artacho A, Isaac S, Nayak R, Flor-Duro A, Alexander M, Koo I, Manasson J, Smith PB, Rosenthal P, Homsi Y, Gulko P, Pons J, Puchades-Carrasco L, Izmirly P, Patterson A, Abramson SB, Pineda-Lucena A, Turnbaugh PJ, Ubeda C, Scher JU (2021) The pretreatment gut microbiome is associated with lack of response to methotrexate in new-onset rheumatoid arthritis. Arthritis Rheumatol 73:931–942
Backhed F, Roswall J, Peng Y, Feng Q, Jia H, Kovatcheva-Datchary P, Li Y, Xia Y, Xie H, Zhong H, Khan MT, Zhang J, Li J, Xiao L, Al-Aama J, Zhang D, Lee YS, Kotowska D, Colding C, Tremaroli V, Yin Y, Bergman S, Xu X, Madsen L, Kristiansen K, Dahlgren J, Wang J (2015) Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 17:852
Balakrishnan B, Taneja V (2018) Microbial modulation of the gut microbiome for treating autoimmune diseases. Expert Rev Gastroenterol Hepatol 12:985–996
Balakrishnan B, Luckey D, Marietta E, Karau M, Patel R, Murray J, Taneja V (2017) Development of a real-time PCR method for quantification of Prevotella histicola from the gut. Anaerobe 48:37–41
Balakrishnan B, Luckey D, Taneja V (2019) Autoimmunity-associated gut commensals modulate gut permeability and immunity in humanized mice. Mil Med 184:529–536
Balakrishnan B, Luckey D, Bodkhe R, Taneja V (2020) Prevotella histicola treatment reduces arthritic pain and partially normalizes gut microbiota and metabolites. J Immunol 204(141):17
Balakrishnan B, Luckey D, Bodhke R, Chen J, Marietta E, Jeraldo P, Murray J, Taneja V (2021a) Prevotella histicola protects from arthritis by expansion of allobaculum and augmenting butyrate production in humanized mice. Front Immunol 12:609644
Balakrishnan B, Selvaraju V, Chen J, Ayine P, Yang L, Ramesh Babu J, Geetha T, Taneja V (2021b) Ethnic variability associating gut and oral microbiome with obesity in children. Gut Microbes 13:1–15
Barbour KE, Helmick CG, Boring M, Brady TJ (2017) Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation - United States, 2013–2015. MMWR Morb Mortal Wkly Rep 66:246–253
Bazin T, Hooks KB, Barnetche T, Truchetet ME, Enaud R, Richez C, Dougados M, Hubert C, Barre A, Nikolski M, Schaeverbeke T (2018) Microbiota composition may predict anti-Tnf alpha response in Spondyloarthritis patients: an exploratory study. Sci Rep 8:5446
Bindels LB, Delzenne NM, Cani PD, Walter J (2015) Towards a more comprehensive concept for prebiotics. Nat Rev Gastroenterol Hepatol 12:303–310
Bodkhe R, Balakrishnan B, Taneja V (2019) The role of microbiome in rheumatoid arthritis treatment. Ther Adv Musculoskelet Dis 11:1–16
Bodkhe R, Marietta EV, Balakrishnan B, Luckey DH, Horwath IE, Shouche YS, Taneja V, Murray JA (2020) Human gut-derived commensal suppresses generation of T-cell response to gliadin in humanized mice by modulating gut microbiota. Anaerobe 68:102237
Braat H, Rottiers P, Hommes DW, Huyghebaert N, Remaut E, Remon JP, Van Deventer SJH, Neirynck S, Peppelenbosch MP, Steidler L (2006) A phase I trial with transgenic bacteria expressing Interleukin-10 in Crohn's disease. Clin Gastroenterol Hepatol 4:754–759
Brandl C, Bucci L, Schett G, Zaiss MM (2021) Crossing the barriers: revisiting the gut feeling in rheumatoid arthritis. Eur J Immunol 51:798–810
Busquets D, Mas-De-Xaxars T, Lopez-Siles M, Martinez-Medina M, Bahi A, Sabat M, Louvriex R, Miquel-Cusachs JO, Garcia-Gil JL, Aldeguer X (2015) Anti-tumour necrosis factor treatment with adalimumab induces changes in the microbiota of Crohn's disease. J Crohns Colitis 9:899–906
Caluwaerts S, Vandenbroucke K, Steidler L, Neirynck S, Vanhoenacker P, Corveleyn S, Watkins B, Sonis S, Coulie B, Rottiers P (2010) AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis. Oral Oncol 46:564–570
Cani PD, Van Hul M (2015) Novel opportunities for next-generation probiotics targeting metabolic syndrome. Curr Opin Biotechnol 32:21–27
Cano-Garrido O, Seras-Franzoso J, Garcia-Fruitos E (2015) Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes. Microb Cell Fact 14:137
Castleman MJ, Dillon SM, Purba CM, Cogswell AC, Kibbie JJ, Mccarter MD, Santiago ML, Barker E, Wilson CC (2019) Commensal and pathogenic bacteria indirectly induce IL-22 but not IFNγ production from human colonic ILC3S via multiple mechanisms. Front Immunol 10:649
Chalan P, Van Den Berg A, Kroesen BJ, Brouwer L, Boots A (2015) Rheumatoid arthritis, Immunosenescence and the hallmarks of aging. Curr Aging Sci 8:131–146
Chen J, Wright K, Davis JM, Jeraldo P, Marietta EV, Murray J, Nelson H, Matteson EL, Taneja V (2016) An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis. Genome Med 8:43
Chen Z, Qian X, Chen SS, Fu XX, Ma GJ, Zhang AQ (2020) Akkermansia muciniphila enhances the antitumor effect of cisplatin in Lewis lung cancer mice. J Immunol Res 2020:2969287
Chen ZN, Zheng XQ, Wu XY, Wu JL, Li XM, Wei QJ, Zhang X, Fang LK, Jin O, Gu JR (2021) Adalimumab therapy restores the gut microbiota in patients with ankylosing spondylitis. Front Immunol 12:700570
Chow J, Lee SM, Shen Y, Khosravi A, Mazmanian SK (2010) Host-bacterial symbiosis in health and disease. Adv Immunol 107:243–274
Cronstein BN (1996) Molecular therapeutics - methotrexate and its mechanism of action. Arthritis Rheum 39:1951–1960
Cunningham MW (2014) Rheumatic fever, autoimmunity, and molecular mimicry: the streptococcal connection. Int Rev Immunol 33:314–329
Dai ZL, Zhang J, Wu GY, Zhu WY (2010) Utilization of amino acids by bacteria from the pig small intestine. Amino Acids 39:1201–1215
Dao MC, Everard A, Aron-Wisnewsky J, Sokolovska N, Prifti E, Verger EO, Kayser BD, Levenez F, Chilloux J, Hoyles L, Dumas ME, Rizkalla SW, Dore J, Cani PD, Clement K, Consortium M-O (2016) Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 65:426–436
De Filippis F, Pasolli E, Tett A, Tarallo S, Naccarati A, De Angelis M, Neviani E, Cocolin L, Gobbetti M, Segata N, Ercolini D (2019) Distinct genetic and functional traits of human intestinal Prevotella copri strains are associated with different habitual diets. Cell Host Microbe 25:444–453.e3
De Oliveira GLV, Leite AZ, Higuchi BS, Gonzaga MI, Mariano VS (2017) Intestinal dysbiosis and probiotic applications in autoimmune diseases. Immunology 152:1–12
De Pablo P, Dietrich T, Mcalindon TE (2008) Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population. J Rheumatol 35:70–76
Depommier C, Everard A, Druart C, Plovier H, Van Hul M, Vieira-Silva S, Falony G, Raes J, Maiter D, Delzenne NM, De Barsy M, Loumaye A, Hermans MP, Thissen JP, De Vos WM, Cani PD (2019) Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med 25:1096–1103
Derrien M, Van Baarlen P, Hooiveld G, Norin E, Muller M, De Vos WM (2011) Modulation Of mucosal immune response, tolerance, and proliferation in mice colonized by the mucin-degrader Akkermansia muciniphila. Front Microbiol 2:166
Derrien M, Belzer C, De Vos WM (2017) Akkermansia muciniphila and its role in regulating host functions. Microb Pathog 106:171–181
Dourado E, Ferro M, Sousa Guerreiro C, Fonseca JE (2020) Diet as a modulator of intestinal microbiota in rheumatoid arthritis. Nutrients 12:3504
Duncan SH, Lobley GE, Holtrop G, Ince J, Johnstone AM, Louis P, Flint HJ (2008) Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes 32:1720–1724
Ebringer A, Rashid T, Wilson C (2010) Rheumatoid arthritis, Proteus, anti-CCP antibodies and Karl popper. Autoimmun Rev 9:216–223
El Hage R, Hernandez-Sanabria E, Van De Wiele T (2017) Emerging trends in “smart probiotics”: functional consideration for the development of novel health and industrial applications. Front Microbiol 8:1889
Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, Muccioli GG, Delzenne NM, De Vos WM, Cani PD (2013) Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A 110:9066–9071
Fan Z, Yang B, Ross RP, Stanton C, Shi G, Zhao J, Zhang H, Chen W (2020) Protective effects of Bifidobacterium adolescentis on collagen-induced arthritis in rats depend on timing of administration. Food Funct 11:4499–4511
Farquharson D, Butcher JP, Culshaw S (2012) Periodontitis, porphyromonas, and the pathogenesis of rheumatoid arthritis. Mucosal Immunol 5:112–120
Farrar MD, Whitehead TR, Lan J, Dilger P, Thorpe R, Holland KT, Carding SR (2005) Engineering of the gut commensal bacterium Bacteroides ovatus to produce and secrete biologically active murine interleukin-2 in response to xylan. J Appl Microbiol 98:1191–1197
Ferrer-Miralles N, Domingo-Espin J, Corchero JL, Vazquez E, Villaverde A (2009) Microbial factories for recombinant pharmaceuticals. Microb Cell Factories 8:17
Ferro M, Charneca S, Dourado E, Guerreiro CS, Fonseca JE (2021) Probiotic supplementation for rheumatoid arthritis: a promising adjuvant therapy in the gut microbiome era. Front Pharmacol 12:711788
Finegold SM, Sutter VL, Mathisen GE (1983) Normal indigenous intestinal Flora. In: Hentges DJ (ed) Human intestinal microflora in health and disease. Academic Press, New York, pp 3–31
Foligne B, Dessein R, Marceau M, Poiret S, Chamaillard M, Pot B, Simonet M, Daniel C (2007) Prevention and treatment of colitis with Lactococcus lactis secreting the Immunomodulatory Yersinia LcrV protein. Gastroenterology 133:862–874
Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, Kato T, Takahashi M, Fukuda NN, Murakami S, Miyauchi E, Hino S, Atarashi K, Onawa S, Fujimura Y, Lockett T, Clarke JM, Topping DL, Tomita M, Hori S, Ohara O, Morita T, Koseki H, Kikuchi J, Honda K, Hase K, Ohno H (2013) Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504:446–450
Galvez EJC, Iljazovic A, Amend L, Lesker TR, Renault T, Thiemann S, Hao LX, Roy U, Gronow A, Charpentier E, Strowig T (2020) Distinct polysaccharide utilization determines interspecies competition between intestinal Prevotella spp. Cell Host Microbe 28:838–852.e6
Gerards AH, De Lathouder S, De Groot ER, Dijkmans BAC, Aarden LA (2003) Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritis. Rheumatology 42:1189–1196
Gibson GR, Roberfroid MB (1995) Dietary modulation of the human colonic microbiota - introducing the concept of prebiotics. J Nutr 125:1401–1412
Gomez A, Luckey D, Yeoman CJ, Marietta EV, Berg Miller ME, Murray JA, White BA, Taneja V (2012) Loss of sex and age driven differences in the gut microbiome characterize arthritis-susceptible 0401 mice but not arthritis-resistant 0402 mice. PLoS One 7:E36095
Gomez-Gallego C, Pohl S, Salminen S, De Vos WM, Kneifel W (2016) Akkermansia muciniphila: a novel functional microbe with probiotic properties. Benefic Microbes 7:571–584
Gregersen PK, Silver J, Winchester RJ (1987) The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30:1205–1213
Guan Y, Jakimovski D, Ramanathan M, Weinstock-Guttman B, Zivadinov R (2019) The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to in vivo imaging. Neural Regen Res 14:373–386
Gupta VK, Cunningham KY, Hur B, Bakshi U, Huang H, Warrington KJ, Taneja V, Myasoedova E, Davis JM, Sung J (2021) Gut microbial determinants of clinically important improvement in patients with rheumatoid arthritis. Genome Med 13:149
Hamady ZZR, Scott N, Farrar MD, Lodge JPA, Holland KT, Whitehead T, Carding SR (2010) Xylan-regulated delivery of human keratinocyte growth Factor-2 to the inflamed colon by the human anaerobic commensal bacterium Bacteroides ovatus. Gut 59:461–469
Hamady ZZR, Scott N, Farrar MD, Wadhwa M, Dilger P, Whitehead TR, Thorpe R, Holland KT, Lodge JPA, Carding SR (2011) Treatment of colitis with a commensal gut bacterium engineered to secrete human TGF-beta 1 under the control of dietary xylan. Inflamm Bowel Dis 17:1925–1935
Hanninen A, Toivonen R, Poysti S, Belzer C, Plovier H, Ouwerkerk JP, Emani R, Cani PD, De Vos WM (2018) Akkermansia muciniphila induces gut microbiota remodelling and controls islet autoimmunity in NOD mice. Gut 67:1445–1453
Hanson ML, Hixon JA, Li WQ, Felber BK, Anver MR, Stewart CA, Janelsins BM, Datta SK, Shen W, Mclean MH, Durum SK (2014) Oral delivery of IL-27 recombinant bacteria attenuates immune colitis in mice. Gastroenterology 146:210–221.e13
Hatakka K, Martio J, Korpela M, Herranen M, Poussa T, Laasanen T, Saxelin M, Vapaatalo H, Moilanen E, Korpela R (2003) Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis--a pilot study. Scand J Rheumatol 32:211–215
Hayashi H, Shibata K, Sakamoto M, Tomita S, Benno Y (2007) Prevotella copri sp. nov and Prevotella stercorea sp. nov., isolated from human faeces. Int J Syst Evol Microbiol 57:941–946
He XY, Zhao SY, Li Y (2021) Faecalibacterium prausnitzii: a next-generation probiotic in gut disease improvement. Can J Infect Dis Med Microbiol 2021:6666114
Hitchon CA, El-Gabalawy HS (2011) Infection and rheumatoid arthritis: still an open question. Curr Opin Rheumatol 23:352–357
Hylemon PB, Harris SC, Ridlon JM (2018) Metabolism of hydrogen gases and bile acids in the gut microbiome. FEBS Lett 592:2070–2082
Ivanov I, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, Wei D, Goldfarb KC, Santee CA, Lynch SV, Tanoue T, Imaoka A, Itoh K, Takeda K, Umesaki Y, Honda K, Littman DR (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:485–498
Joshua V, Schobers L, Titcombe PJ, Israelsson L, Rönnelid J, Hansson M, Catrina AI, Pruijn GJM, Malmström V (2016) Antibody responses to de novo identified citrullinated fibrinogen peptides in rheumatoid arthritis and visualization of the corresponding B cells. Arthritis Res Ther 18:284
Kanerud L, Scheynius A, Nord CE, Hafstrom I (1994) Effect of sulphasalazine on gastrointestinal microflora and on mucosal heat shock protein expression in patients with rheumatoid arthritis. Br J Rheumatol 33:1039–1048
Kelly D, Campbell JI, King TP, Grant G, Jansson EA, Coutts AGP, Pettersson S, Conway S (2004) Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 5:104–112
Kim CH (2018) Immune regulation by microbiome metabolites. Immunology 154:220–229
Klareskog L, Padyukov L, Lorentzen J, Alfredsson L (2006) Mechanisms of disease: genetic susceptibility and environmental triggers in the development of rheumatoid arthritis. Nat Clin Pract Rheumatol 2:425–433
Kohashi O, Kuwata J, Umehara K, Uemura F, Takahashi T, Ozawa A (1979) Susceptibility to adjuvant-induced arthritis among germfree, specific-pathogen-free, and conventional rats. Infect Immun 26:791–794
Langendijk PS, Schut F, Jansen GJ, Raangs GC, Kamphuis GR, Wilkinson MH, Welling GW (1995) Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16s rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol 61:3069–3075
Lee CH, Steiner T, Petrof EO, Smieja M, Roscoe D, Nematallah A, Weese JS, Collins S, Moayyedi P, Crowther M, Ropeleski MJ, Jayaratne P, Higgins D, Li YF, Rau NV, Kim PT (2016) Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent clostridium difficile infection a randomized clinical trial. JAMA 315:142–149
Libao-Mercado AJ, Zhu CL, Cant JP, Lapierre H, Thibault JN, Seve B, Fuller MF, De Lange CF (2009) Dietary and endogenous amino acids are the main contributors to microbial protein in the upper gut of normally nourished pigs. J Nutr 139:1088–1094
Luckey D, Medina K, Taneja V (2012) B cells as effectors and regulators of sex-biased arthritis. Autoimmunity 45:364–376
Lundberg K, Wegner N, Yucel-Lindberg T, Venables PJ (2010) Periodontitis in RA-the citrullinated enolase connection. Nat Rev Rheumatol 6:727–730
Ma N, Ma X (2019) Dietary amino acids and the gut-microbiome-immune axis: physiological metabolism and therapeutic prospects. Compr Rev Food Sci Food Saf 18:221–242
Maeda Y, Kurakawa T, Umemoto E, Motooka D, Ito Y, Gotoh K, Hirota K, Matsushita M, Furuta Y, Narazaki M, Sakaguchi N, Kayama H, Nakamura S, Iida T, Saeki Y, Kumanogoh A, Sakaguchi S, Takeda K (2016) Dysbiosis contributes to arthritis development via activation of autoreactive T cells in the intestine. Arthritis Rheumatol 68:2646–2661
Maier E, Anderson RC, Roy NC (2015) Understanding how commensal obligate anaerobic bacteria regulate immune functions in the large intestine. Nutrients 7:45–73
Malmström V, Catrina AI, Klareskog L (2017) The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting. Nat Rev Immunol 17:60–75
Mandel DR, Eichas K, Holmes J (2010) Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial. BMC Complement Altern Med 10:1–1
Mangalam A, Shahi SK, Luckey D, Karau M, Marietta E, Luo NL, Choung RS, Ju J, Sompallae R, Gibson-Corley K, Patel R, Rodriguez M, David C, Taneja V, Murray J (2017) Human gut-derived commensal bacteria suppress CNS inflammatory and demyelinating disease. Cell Rep 20:1269–1277
Marietta E, Rishi A, Taneja V (2015) Immunogenetic control of the intestinal microbiota. Immunology 145:313–322
Marietta EV, Murray JA, Luckey DH, Jeraldo PR, Lamba A, Patel R, Luthra HS, Mangalam A, Taneja V (2016) Suppression of inflammatory arthritis by human gut-derived Prevotella histicola in humanized mice. Arthritis Rheumatol 68:2878–2888
Marietta E, Horwath I, Balakrishnan B, Taneja V (2019) Role of the intestinal microbiome in autoimmune diseases and its use in treatments. Cell Immunol 339:50–58
Martin R, Miquel S, Benevides L, Bridonneau C, Robert V, Hudault S, Chain F, Berteau O, Azevedo V, Chatel JM, Sokol H, Bermudez-Humaran LG, Thomas M, Langella P (2017) Functional characterization of novel Faecalibacterium prausnitzii strains isolated from healthy volunteers: a step forward in the use of F. Prausnitzii as a next-generation probiotic. Front Microbiol 8:226
Matzinger P (1998) An innate sense of danger. Semin Immunol 10:399–415
Mazmanian SK, Round JL, Kasper DL (2008) A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453:620–625
Mccarville JL, Caminero A, Verdu EF (2016) Novel perspectives on therapeutic modulation of the gut microbiota. Ther Adv Gastroenterol 9:580–593
Mcgraw WT, Potempa J, Farley D, Travis J (1999) Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase. Infect Immun 67:3248–3256
Mikuls TR, Thiele GM, Deane KD, Payne JB, O'Dell JR, Yu F, Sayles H, Weisman MH, Gregersen PK, Buckner JH, Keating RM, Derber LA, Robinson WH, Holers VM, Norris JM (2012) Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis. Arthritis Rheum 64:3522–3530
Mikuls TR, Payne JB, Yu F, Thiele GM, Reynolds RJ, Cannon GW, Markt J, Mcgowan D, Kerr GS, Redman RS, Reimold A, Griffiths G, Beatty M, Gonzalez SM, Bergman DA, Hamilton BC 3rd, Erickson AR, Sokolove J, Robinson WH, Walker C, Chandad F, O'dell, J. R. (2014) Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis. Arthritis Rheumatol 66:1090–1100
Nayak RR, Alexander M, Deshpande I, Stapleton-Gray K, Rimal B, Patterson AD, Ubeda C, Scher JU, Turnbaugh PJ (2021) Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation. Cell Host Microbe 29:362–377.e11
Newkirk MM, Zbar A, Baron M, Manges AR (2010) Distinct bacterial colonization patterns of Escherichia coli subtypes associate with rheumatoid factor status in early inflammatory arthritis. Rheumatology 49:1311–1316
Onuora S (2021) New insights into RA genetics from GWAS meta-analysis. Nat Rev Rheumatol 17:128–128
Pabst O, Slack E (2020) IgA and the intestinal microbiota: the importance of being specific. Mucosal Immunol 13:12–21
Park J, Kim M, Kang SG, Jannasch AH, Cooper B, Patterson J, Kim CH (2015) Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunol 8:80–93
Peppercorn MA (1984) Sulfasalazine - pharmacology, clinical use, toxicity, and related new drug development. Ann Intern Med 101:377–386
Pianta A, Arvikar S, Strle K, Drouin EE, Wang Q, Costello CE, Steere AC (2017) Evidence of the immune relevance of Prevotella copri, a gut microbe, in patients with rheumatoid arthritis. Arthritis Rheumatol 69:964–975
Picchianti-Diamanti A, Panebianco C, Salemi S, Sorgi ML, Di Rosa R, Tropea A, Sgrulletti M, Salerno G, Terracciano F, D'amelio R, Lagana B, Pazienza V (2018) Analysis of gut microbiota in rheumatoid arthritis patients: disease-related dysbiosis and modifications induced by etanercept. Int J Mol Sci 19:2938
Pineda MD, Thompson SF, Summers K, De Leon F, Pope J, Reid G (2011) A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis. Med Sci Monit 17:CR347–CR354
Qiu XY, Zhang MM, Yang XT, Hong N, Yu CG (2013) Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis. J Crohns Colitis 7:E558–E568
Ramakrishna C, Kujawski M, Chu H, Li L, Mazmanian SK, Cantin EM (2019) Bacteroides fragilis polysaccharide A induces IL-10 secreting B and T cells that prevent viral encephalitis. Nat Commun 10:2153
Raychaudhuri S, Sandor C, Stahl EA, Freudenberg J, Lee H-S, Jia X, Alfredsson L, Padyukov L, Klareskog L, Worthington J, Siminovitch KA, Bae S-C, Plenge RM, Gregersen PK, De Bakker PIW (2012) Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 44:291–296
Robert S, Steidler L (2014) Recombinant Lactococcus lactis can make the difference in antigen-specific immune tolerance induction, the type 1 diabetes case. Microb Cell Fact 13(Supp 1):S11
Rojas M, Restrepo-Jimenez P, Monsalve DM, Pacheco Y, Acosta-Ampudia Y, Ramirez-Santana C, Leung PSC, Ansari AA, Gershwin ME, Anaya JM (2018) Molecular mimicry and autoimmunity. J Autoimmun 95:100–123
Rook GA, Brunet LR (2005) Microbes, immunoregulation, and the gut. Gut 54:317–320
Rosser EC, Oleinika K, Tonon S, Doyle R, Bosma A, Carter NA, Harris KA, Jones SA, Klein N, Mauri C (2014) Regulatory B cells are induced by gut microbiota-driven interleukin-1beta and interleukin-6 production. Nat Med 20:1334–1339
Rossi O, Van Berkel LA, Chain F, Khan MT, Taverne N, Sokol H, Duncan SH, Flint HJ, Harmsen HJM, Langella P, Samsom JN, Wells JM (2016) Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses. Sci Rep 6:18507
Round JL, O'connell RM, Mazmanian SK (2010) Coordination of tolerogenic immune responses by the commensal microbiota. J Autoimmun 34:J220–J225
Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, Mazmanian SK (2011) The toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332:974–977
Rudbane SMA, Rahmdel S, Abdollahzadeh SM, Zare M, Bazrafshan A, Mazloomi SM (2018) The efficacy of probiotic supplementation in rheumatoid arthritis: a meta-analysis of randomized, controlled trials. Inflammopharmacology 26:67–76
Sato N, Oizumi T, Kinbara M, Sato T, Funayama H, Sato S, Matsuda K, Takada H, Sugawara S, Endo Y (2010) Promotion of arthritis and allergy in mice by aminoglycoglycerophospholipid, a membrane antigen specific to Mycoplasma fermentans. FEMS Immunol Med Microbiol 59:33–41
Sayers E, Macgregor A, Carding SR (2018) Drug-microbiota interactions and treatment response: relevance to rheumatoid arthritis. Aims Microbiol 4:642–654
Scher JU, Sczesnak A, Longman RS, Segata N, Ubeda C, Bielski C, Rostron T, Cerundolo V, Pamer EG, Abramson SB, Huttenhower C, Littman DR (2013) Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2:e01202
Schweitzer BI, Dicker AP, Bertino JR (1990) Dihydrofolate-reductase as a therapeutic target. FASEB J 4:2441–2452
Schwenzer A, Quirke AM, Marzeda AM, Wong A, Montgomery AB, Sayles HR, Eick S, Gawron K, Chomyszyn-Gajewska M, Lazarz-Bartyzel K, Davis S, Potempa J, Kessler BM, Fischer R, Venables PJ, Payne JB, Mikuls TR, Midwood KS (2017) Association of distinct fine specificities of anti-citrullinated peptide antibodies with elevated immune responses to Prevotella intermedia in a subgroup of patients with rheumatoid arthritis and periodontitis. Arthritis Rheumatol 69:2303–2313
Seitz M, Zwicker M, Wider B (2001) Enhanced in vitro induced production of interleukin 10 by peripheral blood mononuclear cells in rheumatoid arthritis is associated with clinical response to methotrexate treatment. J Rheumatol 28:496–501
Shi N, Zhang SY, Silverman G, Li MT, Cai J, Niu HT (2019) Protective effect of hydroxychloroquine on rheumatoid arthritis-associated atherosclerosis. Animal Mod Exp Med 2:98–106
Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M, Glickman JN, Garrett WS (2013) The microbial metabolites, short-chain fatty acids, regulate colonic T-reg cell homeostasis. Science 341:569–573
Song Y, Garg S, Girotra M, Maddox C, Von Rosenvinge EC, Dutta A, Dutta S, Fricke WF (2013) Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection. PLoS One 8:e81330
Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP, Li Y, Kurreeman FA, Zhernakova A, Hinks A, Guiducci C, Chen R, Alfredsson L, Amos CI, Ardlie KG, Barton A, Bowes J, Brouwer E, Burtt NP, Catanese JJ, Coblyn J, Coenen MJ, Costenbader KH, Criswell LA, Crusius JB, Cui J, De Bakker PI, De Jager PL, Ding B, Emery P, Flynn E, Harrison P, Hocking LJ, Huizinga TW, Kastner DL, Ke X, Lee AT, Liu X, Martin P, Morgan AW, Padyukov L, Posthumus MD, Radstake TR, Reid DM, Seielstad M, Seldin MF, Shadick NA, Steer S, Tak PP, Thomson W, Van Der Helm-Van Mil AH, Van Der Horst-Bruinsma IE, Van Der Schoot CE, Van Riel PL, Weinblatt ME, Wilson AG, Wolbink GJ, Wordsworth BP, Wijmenga C, Karlson EW, Toes RE, De Vries N, Begovich AB, Worthington J, Siminovitch KA, Gregersen PK, Klareskog L, Plenge RM (2010) Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 42:508–514
Stastny P (1978) Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 298:869–871
Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, Fiers W, Remaut E (2000) Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289:1352–1355
Takiishi T, Korf H, Van Belle TL, Robert S, Grieco FA, Caluwaerts S, Galleri L, Spagnuolo I, Steidler L, Van Huynegem K, Demetter P, Wasserfall C, Atkinson MA, Dotta F, Rottiers P, Gysemans C, Mathieu C (2012) Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice. J Clin Investig 122:1717–1725
Taneja V (2017a) Microbiome in 2016: T follicular helper cells and the gut microbiome in arthritis. Nat Rev Rheumatol 13:72–74
Taneja V (2017b) T follicular helper cells and the gut microbiome in arthritis. Nat Rev Rheumatol 13:72–74
Taneja V, David CS (2010) Role of HLA class II genes in susceptibility/resistance to inflammatory arthritis: studies with humanized mice. Immunol Rev 233:62–78
Tannock GW, Munro K, Harmsen HJ, Welling GW, Smart J, Gopal PK (2000) Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl Environ Microbiol 66:2578–2588
Vaahtovuo J, Munukka E, Korkeamaki M, Luukkainen R, Toivanen P (2008) Fecal microbiota in early rheumatoid arthritis. J Rheumatol 35:1500–1505
Vaghef-Mehrabany E, Alipour B, Homayouni-Rad A, Sharif S-K, Asghari-Jafarabadi M, Zavvari S (2014) Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis. Nutrition 30:430–435
Van Vollenhoven RF, Mcguire JL (1994) Estrogen, progesterone, and testosterone: can they be used to treat autoimmune diseases? Cleve Clin J Med 61:276–284
Vandenbroek MF, Vanbruggen MCJ, Koopman JP, Hazenberg MP, Vandenberg WB (1992) Gut flora induces and maintains resistance against streptococcal cell wall-induced arthritis in F344 rats. Clin Exp Immunol 88:313–317
Vandenbroucke K, De Haard H, Beirnaert E, Dreier T, Lauwereys M, Huyck L, Van Huysse J, Demetter P, Steidler L, Remaut E, Cuvelier C, Rottiers P (2010) Orally administered L. Lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis. Mucosal Immunol 3:49–56
Vassallo R, Luckey D, Behrens M, Madden B, Luthra H, David C, Taneja V (2014) Cellular and humoral immunity in arthritis are profoundly influenced by the interaction between cigarette smoke effects and host HLA-DR and DQ genes. Clin Immunol 152:25–35
Ventura M, Turroni F, Canchaya C, Vaughan EE, O'Toole PW, Van Sinderen D (2009) Microbial diversity in the human intestine and novel insights from metagenomics. Front Biosci 14:3214–3221
Wang YL, Wang BH, Wu JF, Jiang XY, Tang HR, Nielsen OH (2017) Modulation of gut microbiota in pathological states. Engineering 3:83–89
Watterlot L, Rochat T, Sokol H, Cherbuy C, Bouloufa I, Lefevre F, Gratadoux JJ, Honvo-Hueto E, Chilmonczyk S, Blugeon S, Corthier G, Langella P, Bermudez-Humaran LG (2010) Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice. Int J Food Microbiol 144:35–41
Wegner N, Wait R, Sroka A, Eick S, Nguyen KA, Lundberg K, Kinloch A, Culshaw S, Potempa J, Venables PJ (2010) Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and alpha-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum 62:2662–2672
Weingarden A, Gonzalez A, Vazquez-Baeza Y, Weiss S, Humphry G, Berg-Lyons D, Knights D, Unno T, Bobr A, Kang J, Khoruts A, Knight R, Sadowsky MJ (2015) Dynamic changes in short- and long-term bacterial composition following fecal microbiota transplantation for recurrent Clostridium difficile infection. Microbiome 3:10
Whelan RA, Rausch S, Ebner F, Gunzel D, Richter JF, Hering NA, Schulzke JD, Kuhl AA, Keles A, Janczyk P, Nockler K, Wieler LH, Hartmann S (2014) A transgenic probiotic secreting a parasite immunomodulator for site-directed treatment of gut inflammation. Mol Ther 22:1730–1740
Wrzosek L, Miquel S, Noordine ML, Bouet S, Chevalier-Curt MJ, Robert V, Philippe C, Bridonneau C, Cherbuy C, Robbe-Masselot C, Langella P, Thomas M (2013) Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol 11:61
Wu HJ, Ivanov II, Darce J, Hattori K, Shima T, Umesaki Y, Littman DR, Benoist C, Mathis D (2010) Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32:815–827
Xu MQ, Cao HL, Wang WQ, Wang S, Cao XC, Yan F, Wang BM (2015) Fecal microbiota transplantation broadening its application beyond intestinal disorders. World J Gastroenterol 21:102–111
Zamani B, Golkar HR, Farshbaf S, Emadi-Baygi M, Tajabadi-Ebrahimi M, Jafari P, Akhavan R, Taghizadeh M, Memarzadeh MR, Asemi Z (2016) Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. Int J Rheum Dis 19:869–879
Zeng JQ, Peng LH, Zheng W, Huang F, Zhang NN, Wu D, Yang YS (2021) Fecal microbiota transplantation for rheumatoid arthritis: a case report. Clin Case Rep 9:906–909
Zhang X, Zhang D, Jia H, Feng Q, Wang D, Liang D, Wu X, Li J, Tang L, Li Y, Lan Z, Chen B, Li Y, Zhong H, Xie H, Jie Z, Chen W, Tang S, Xu X, Wang X, Cai X, Liu S, Xia Y, Li J, Qiao X, Al-Aama JY, Chen H, Wang L, Wu QJ, Zhang F, Zheng W, Li Y, Zhang M, Luo G, Xue W, Xiao L, Li J, Chen W, Xu X, Yin Y, Yang H, Wang J, Kristiansen K, Liu L, Li T, Huang Q, Li Y, Wang J (2015a) The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med 21:895–905
Zhang X, Zhang D, Jia H, Feng Q, Wang D, Liang D, Wu X, Li J, Tang L, Li Y, Lan Z, Chen B, Zhong H, Xie H, Jie Z, Chen W, Tang S, Xu X, Wang X, Cai X, Liu S, Xia Y, Qiao X, Al-Aama JY, Chen H, Wang L, Wu QJ, Zhang F, Zheng W, Zhang M, Luo G, Xue W, Xiao L, Yin Y, Yang H, Wang J, Kristiansen K, Liu L, Li T, Huang Q (2015b) The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med 21:895–905
Zhang JB, Huang YJ, Yoon JY, Kemmitt J, Wright C, Schneider K, Sphabmixay P, Hernandez-Gordillo V, Holcomb SJ, Bhushan B, Rohatgi G, Benton K, Carpenter D, Kester JC, Eng G, Breault DT, Yilmaz O, Taketani M, Voigt CA, Carrier RL, Trumper DL, Griffith LG (2021) Primary human colonic mucosal barrier crosstalk with super oxygen-sensitive Faecalibacterium prausnitzii in continuous culture. Med (N Y) 2:74–98.e9
Zhao Y, Wu J, Li JV, Zhou NY, Tang H, Wang Y (2013) Gut microbiota composition modifies fecal metabolic profiles in mice. J Proteome Res 12:2987–2999
Zhou BL, Xia XY, Wang PQ, Chen S, Yu CH, Huang R, Zhang R, Wang YT, Lu L, Yuan FJ, Tian YM, Fan YZ, Zhang XY, Shu Y, Zhang SY, Bai D, Wu L, Xu H, Yan L (2018) Induction and amelioration of methotrexate-induced gastrointestinal toxicity are related to immune response and gut microbiota. EBioMedicine 33:122–133
Zou F, Qiu Y, Huang Y, Zou H, Cheng X, Niu Q, Luo A, Sun J (2021) Effects of short-chain fatty acids in inhibiting HDAC and activating P38 MAPK are critical for promoting B10 cell generation and function. Cell Death Dis 12:582
Acknowledgments
The work was supported by the funds from the Department of Defense W81XWH-10-1-0257 and W81XWH-15-1-0213 and Mayo Clinic.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Balakrishnan, B., Taneja, V. (2022). Microorganisms in Pathogenesis and Management of Rheumatoid Arthritis. In: Dwivedi, M.K., Amaresan, N., Kemp, E.H., Shoenfeld, Y. (eds) Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-19-1946-6_16
Download citation
DOI: https://doi.org/10.1007/978-981-19-1946-6_16
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-19-1945-9
Online ISBN: 978-981-19-1946-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)